News

We are excited to share the New RO1 that our Mulva Faculty Jared Benge was awarded. The project focusses on Mild Cognitive Impairment and Dementia. Difficulties with prospective memory, such as remembering to take medications, represent a signature decline in mild dementia, worsen quality of life and independence, and add… read more 

  Pediatric neurologist Audrey Brumback, MD, PhD, was a featured guest on the September 8 episode of the National Institute of Neurological Disorders and Stroke’s Building Up the Nerve podcast, designed to help neuroscience trainees navigate the life cycle of a grant application. In this episode, “Demystifying Clinician-Scientist Careers,” Brumback… read more 

The important role of genetics in autism development has become increasingly obvious. Many genes implicated in autism are so fundamental to basic neurobiology that species as diverse as worms and humans share them. After discovering that natural variability in autism-related genes correlates with alterations in worm social behavior, Audrey Brumback,… read more 

  Steve Roach, MD, was recently interviewed by the Austin American-Statesman about how a 13-year-old boy who suffered a stroke could change the stroke protocol at Dell Children’s and other children’s hospitals. Roach wrote the first statement on pediatric strokes for the American Heart Association/American Stroke Association in 2008 and… read more 

UT Health Austin clinician-researchers work to understand and address the elevated risk of Alzheimer’s disease among Hispanic older adults According to the Alzheimer’s Association, Hispanic older adults are at a disproportionate risk for Alzheimer’s disease in the United States, with some studies estimating that Hispanic older adults are 1.5 times… read more 

Dr. Nicholas M. Barbaro received the prestigious “Distinguished Service Awardees” from the The Society of Neurological Surgeons at the 2023 Annual Meeting in Dallas

The week of March  20, UT Health Austin’s Bipolar Disorder Center within the Mulva Clinic for the Neurosciences successfully completed the first SAINT protocol in Texas, and join institutions like Stanford, Harvard and John Hopkins as the only few sites proving this groundbreaking intervention to treat depression. The SAINT protocol received FDA… read more